Metraipolis › archive › dc_227dfa03befe
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry — Europe PMC PMID:41514633
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41514633
- DOI
- 10.3390/cancers18010124
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T07:47:47.655Z
- SHA-256 of the archived text
a7146e172c06157504272040e211ef53b3a9d7bd63fad24f9abcc4f803b20446- Stable URL of this page
https://metraipolis.com/documento/dc_227dfa03befe
How to cite
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry — Europe PMC PMID:41514633 — Europe PMC (en), https://europepmc.org/article/MED/41514633 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_227dfa03befe (Metraipolis archive dc_227dfa03befe, sha256 a7146e172c06157504272040e211ef53b3a9d7bd63fad24f9abcc4f803b20446)
BibTeX
@misc{dc227dfa03befe,
title = {High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry — Europe PMC PMID:41514633},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41514633},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_227dfa03befe; sha256 a7146e172c06157504272040e211ef53b3a9d7bd63fad24f9abcc4f803b20446},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41514633. Agents can read the archived copy with the MCP tool read_document.